首页> 外文期刊>Nature reviews. Gastroenterology & hepatology >Clinical guidelines: Secondary prevention of gastric cancer
【24h】

Clinical guidelines: Secondary prevention of gastric cancer

机译:临床指南:胃癌的二级预防

获取原文
获取原文并翻译 | 示例
           

摘要

The second half of the 20th century saw the elucidation of the gastric oncogenic cascade, which culminates in gastric cancer. Culture of Helicobacter pylori established that this bacterium was the most common cause of active chronic gastritis, peptic ulcer and gastric cancer. Although environmental factors seem to be the main causes of these diseases, host-related immunological mechanisms could have a role in modulating the severity of the gastric disease. This clinicobiological information has been slow to diffuse into the medical community, and it has only just begun to have a major effect on the daily practice of clinicians and patholo-gists. However, a number of conclusions have been reached that can, and should, directly affect clinical practice.
机译:20世纪后半叶,对胃癌致癌级联的阐明(最终在胃癌中达到顶峰)得以阐明。幽门螺杆菌的培养确定该细菌是活动性慢性胃炎,消化性溃疡和胃癌的最常见原因。尽管环境因素似乎是造成这些疾病的主要原因,但与宿主相关的免疫机制可能在调节胃病的严重程度方面起作用。这种临床生物学信息传播到医学界的速度很慢,它才刚刚开始对临床医生和病理学家的日常操作产生重大影响。但是,已经得出了可以并且应该直接影响临床实践的许多结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号